Radiopharmaceuticals for sentinel lymph node detection status and trends /

This book summarizes the current status and future trends in the development of radiopharmaceuticals for sentinel lymph node detection (SLND), an essential diagnostic tool for the effective treatment of superficial cancers such as breast tumours and melanoma. The publication covers all current aspec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Otros Autores: International Atomic Energy Agency.
Formato: Sin ejemplares
Lenguaje:Inglés
Publicado: Vienna : IAEA, 2015.
Colección:IAEA Radioisotopes and Radiopharmaceuticals Series, no. 6
Materias:
Acceso en línea:Texto completo
Tapa
LEADER 02286nam#a22003615a#4500
001 BCCAB018084
008 150820s2015####au#a###fsb####001#0#eng#d
005 20151112104317.0
003 AR-BCCAB
245 0 0 |a Radiopharmaceuticals for sentinel lymph node detection  |h [recurso electrónico] :  |b status and trends /  |c International Atomic Energy Agency. 
260 # # |a Vienna :  |b IAEA,  |c 2015. 
300 # # |a 162 p. :  |b il. (algunas col.), tablas ;  |c 24 cm. 
490 0 # |a IAEA Radioisotopes and Radiopharmaceuticals Series,  |x 2077-6462 ;  |v no. 6 
500 # # |a STI/PUB/1674. 
500 # # |a Título tomado de la versión electrónica (consultado: 20.08.15). 
504 # # |a Includes bibliographical references. 
520 # # |a This book summarizes the current status and future trends in the development of radiopharmaceuticals for sentinel lymph node detection (SLND), an essential diagnostic tool for the effective treatment of superficial cancers such as breast tumours and melanoma. The publication covers all current aspects of this diagnostic methodology, including the production of nanocolloidal particles, their biological mechanism of action and relevant clinical applications. It also illustrates the recent developments in the field fuelled by the introduction of molecular imaging agents for SLND and of multimodality optical and radioactive agents. Included in the results presented in this book, are those on the novel generation of SLND radiopharmaceuticals obtained through an IAEA coordinated research project. 
538 # # |a Modo de acceso: World Wide Web. 
020 # # |a 9789201097149 
710 2 # |a International Atomic Energy Agency. 
080 # # |a 61:621.039 
650 # 7 |a Radioactive tracers  |2 inist 
650 # 7 |a Lymph nodes - Biopsy  |2 inist 
650 # 7 |a Cancer - Diagnosis  |2 inist 
650 # 7 |a Radiopharmaceuticals  |2 inist 
650 # 7 |a Trazadores radiactivos  |2 inist 
650 # 7 |a Ganglios linfáticos  |2 inist 
650 # 7 |a Radiofarmacos  |2 inist 
040 # # |a arbccab  |b spa 
856 4 0 |q pdf  |s 2.489 Kb  |u http://www-pub.iaea.org/MTCD/Publications/PDF/Pub1674web-3264500.pdf  |3 Texto completo 
856 4 0 |u http://campi.cab.cnea.gov.ar/tocs/tapas/p1674cov-28272435.jpg  |3 Tapa 
942 # # |c BK 
952 # # |2 udc  |7 NOT_LOAN  |a ARBCCAB  |b ARBCCAB  |i 018084_nuevo-0  |o Acceso Web  |p 018084_nuevo-0  |t 1  |y VM